Effectiveness of postoperative adjuvant therapy with cytotoxic chemotherapy (cytosine arabinoside, mitomycin C, 5-fluorouracil) or immunotherapy (neuraminidase-modified allogeneic cells) in the prevention of recurrence of Duke's B and C colon cancer.
D000368:Aged; D003110:Colonic Neoplasms / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D003561:Cytarabine / Q000627:therapeutic use; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D008297:Male; D008875:Middle Aged; D016685:Mitomycin; D008937:Mitomycins / Q000627:therapeutic use; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D009439:Neuraminidase / Q000494:pharmacology; D014611:Vaccination
D008937:Mitomycins; D003561:Cytarabine; D016685:Mitomycin; D009439:Neuraminidase; D005472:Fluorouracil